Global Smart Drug Delivery Systems Market Report 2025: Market Opportunities & Challenges Outlook

 For organizations targeting expansion, this report delivers actionable intelligence on how the smart drug delivery systems industry is evolving.

 

 What Is The Current Outlook For The Smart Drug Delivery Systems Market?
 The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $12.65 billion in 2024 to $15.06 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.
 
 The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $29.19 billion in 2029 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp
 
 What Are The Driving Factors Impacting The Smart Drug Delivery Systems Market?
 The rising prevalence of chronic diseases is expected to propel the growth of the smart drug delivery systems market going forward. Chronic diseases are long-term health conditions that progress slowly over time and often have complex causes. The prevalence of chronic diseases is increasing due to aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising approach to managing chronic diseases by enhancing medication effectiveness and increasing patient adherence. For instance, in January 2023, according to the National Library of Medicine, the US-based medical library, by 2050, there will be 142.66 million people with at least one chronic illness, a 99.5% rise from 71.522 million in 2020. Therefore, the rising prevalence of chronic diseases is driving the smart drug delivery systems market.
 
 Analysis Of Major Segments Driving The Smart Drug Delivery Systems Market Growth
 The smart drug delivery systemsmarket covered in this report is segmented — 
 
 1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products
 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas
 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users
 
 Subsegments:
 1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs) 
 2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors 
 3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors 
 4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors 
 5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors 
 6) By Other Products: Smart Syringes; Smart Patches; Smart Implants
 
 Emerging Trends And Strategic Opportunities In The Smart Drug Delivery Systems Market
 Major companies operating in the smart drug delivery systems market focus on developing reusable drug delivery devices, such as Qfinity, to revolutionize drug administration. Qfinity is a reusable drug delivery device used to administer medication, unlike single-use devices that are disposed of after one use. For instance, in May 2022, Jabil Inc., a US-based manufacturing services company, launched Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of drugs. The device is capable of handling over 100 injections per device, accommodating 1 mL or 2.25 mL pre-filled cartridges and offering a 60% reduction in carbon footprint per injection. The Qfinity autoinjector platform is versatile, featuring broad technical specifications for drug volumes and viscosities. Additionally, a connected version called Qfinity+ allows for remote monitoring of patients’ care and compliance through built-in sensors and electronics, providing connectivity without compromising ease of use.
 
 Which Are The Top Players Involved In Smart Drug Delivery Systems Market?
 Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation
 
 View the full smart drug delivery systems market report here:
 https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report
 
 Which Region Drives The Most Demand In The Smart Drug Delivery Systems Market?
 North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company